Disclosure Panels Details Page
Myeloproliferative Neoplasms Panel - Disclosures as of 05/29/2023
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Peter Abdelmessieh DO,MSc | None | Bristol-Myers Squibb Company | None | None | 03/21/2023 |
| Haris Ali MD | CTI BioPharma Corp. Incyte Corporation Karyopharm Therapeutics LNK Biopharma Stemline |
AbbVie, Inc. Incyte Corporation Karyopharm Therapeutics |
Blueprint Medicines Bristol-Myers Squibb Company Incyte Corporation |
None | 08/22/2022 |
| Mary Anne Bergman | None | None | None | None | 03/29/2023 |
| Marian Birkeland PhD | None | None | None | None | 12/12/2022 |
| Nicole Blankenhorn | None | None | None | None | 03/21/2023 |
| Prithviraj Bose MD | Blueprint Medicines Bristol-Myers Squibb Company Celgene Corporation Cogent Constellation Pharmaceuticals CTI BioPharma Corp. Incyte Corporation Kartos Therapeutics |
None | AbbVie, Inc. Blueprint Medicines Bristol-Myers Squibb Company CTI BioPharma Corp. Incyte Corporation Karyopharm Therapeutics MorphoSys AG Pharma Essentia Sierra Oncology |
None | 05/22/2022 |
| Mariana Castells PhD,MD | Blueprint Medicines Cogent Biosciences NIHDSMB Allergy Clinical Trials |
AAAAI Foundation Board of Directors ABAI Board of Directors Daiichi Sankyo Inc The Mastocytosis Society Medical Advisory Board |
None | None | 01/12/2023 |
| Andrew Dunbar MD | None | Incyte Corporation | None | None | 03/08/2023 |
| Tracy George MD | None | Blueprint Medicines Cogent Biosciences Incyte Corporation Integritas Communications |
E Squared The CM Group |
ARUP Laboratories | 02/07/2023 |
| Aaron Gerds MS,MD | CTI BioPharma Corp. Imago Biosciences MorphoSys AG Protagonist Sierra Oncology |
AbbVie, Inc. CTI BioPharma Corp. Imago MorphoSys AG PharmaEssentia Sierra Oncology |
None | None | 08/01/2022 |
| Jason Gotlib MS,MD | AbbVie, Inc. Blueprint Medicines Bristol-Myers Squibb Company Celgene Corporation Cogent Biosciences Deciphera Pharmaceuticals, Inc. Incyte Corporation Kartos PharmaEssentia Promedior, Inc. Protagonist Therapeutics |
AbbVie, Inc. Blueprint Medicines Cogent Biosciences Incyte Corporation PharmaEssentia |
None | None | 05/06/2022 |
| Steven Green MD | AbbVie, Inc. Boston Biomedical |
None | CTI BioPharma Corp. | None | 04/14/2023 |
| Kristina Gregory MSN,RN,OCN | None | None | None | None | 03/13/2023 |
| Krishna Gundabolu MBBS,MS,FACP | None | Blueprint Medicines Bristol-Myers Squibb Company CTI BioPharma Corp. sanofi-aventis U.S. Spark Therapeutics |
None | Stock in Geron | 01/03/2023 |
| Evelyn Handel BCPS,PharmD,BCOP | None | None | None | None | 04/28/2023 |
| Laura Hanisch PsyD | None | None | None | None | 12/13/2022 |
| Kyle Herrmann BSN,RN,OCN | None | None | None | None | 03/06/2023 |
| Erin Hesler | None | None | None | None | 04/04/2023 |
| Elizabeth Hexner MD | American Board of Internal Medicine Blueprint Medicines Bristol-Myers Squibb Company Tmunity |
AbbVie, Inc. PharmaEssentia |
None | None | 08/15/2022 |
| Gabriela Hobbs MD | None | AbbVie, Inc. Bristol-Myers Squibb Company Cogent Incyte Corporation MorphoSys AG Novartis Pharmaceuticals Corporation Pfizer Inc. Pharmaessentia Pharmaxis Protagonist |
None | None | 01/10/2023 |
| Cindy Hochstetler PhD | None | None | None | None | 03/03/2023 |
| Tania Jain MBBS | None | None | AbbVie, Inc. Blueprint Medicines Bristol-Myers Squibb Company cogent biosciences inc CTI BioPharma Corp. Incyte Corporation Kite Pharma Takeda Pharmaceuticals North America, Inc. Telio pharma |
None | 02/25/2023 |
| Catriona Jamieson PhD,MD | None | None | None | Aspera Biomedicines|Forty Seven, Inc. | 06/13/2022 |
| Paul Kaesberg MD | None | None | BeiGene Incyte Corporation Janssen Pharmaceutica Products, LP |
None | 03/23/2023 |
| Andrew Kuykendall MD | Blueprint Medicines Bristol-Myers Squibb Company Geron GlaxoSmithKline Incyte Corporation MorphoSys AG Protagonist |
None | AbbVie, Inc. Blueprint Medicines Celgene Corporation Cogent GlaxoSmithKline Incyte Corporation MorphoSys AG |
None | 04/10/2023 |
| Yazan Madanat MD | None | Blueprint Medicines GERON Novartis Pharmaceuticals Corporation Sierra Oncology Taiho Pharmaceuticals Co., Ltd. |
None | None | 05/25/2022 |
| Naveen Manchanda MD | None | None | None | None | 03/31/2023 |
| Brandon McMahon MD | None | CTI BioPharma Corp. | CTI BioPharma Corp. | None | 08/15/2022 |
| Sanjay Mohan MD,MSCI | Incyte Corporation Karyopharm Therapeutics Taiho Pharmaceuticals Co., Ltd. |
None | None | None | 03/25/2023 |
| Kalyan Nadiminti MD | None | MorphoSys AG | None | None | 05/07/2023 |
| Stephen Oh PhD,MD | None | AbbVie, Inc. Bristol-Myers Squibb Company Cogent Constellation CTI BioPharma Corp. Geron Incyte Corporation Protagonist Sierra Oncology |
None | None | 02/25/2023 |
| Jeanne Palmer MD | CTI BioPharma Corp. Incyte Corporation Morphosys Pharmessentia Protagonist Sierra Oncology |
MorphoSys AG | None | None | 02/10/2023 |
| Sharon Park PharmD,BCOP | None | None | None | None | 05/09/2023 |
| Nikolai Podoltsev PhD,MD | AI Therapeutics Aptose Biosciences Arog Pharmaceuticals Astellas Pharma US, Inc. Astex Pharmaceuticals Boehringer Ingelheim GmbH Celgene Corporation CTI BioPharma Corp. Daiichi- Sankyo Co. Genentech, Inc. Jazz Pharmaceuticals Inc. MorphoSys AG Pfizer Inc. Sunesis Pharmaceuticals, Inc. Syneos Health |
AbbVie, Inc. Blueprint Medicines CTI BioPharma Corp. Incyte Corporation Novartis Pharmaceuticals Corporation PharmaEssentia |
None | None | 04/13/2023 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 05/11/2023 |
| Sheeja Pullarkat MD | None | None | Blueprint Medicines EUSA Stemline |
None | 03/06/2023 |
| Lindsay Rein MD | Actuate Therapeutics Blueprint Medicines Boston Biomedical Celgene Corporation CTI BioPharma Corp. Imago Incyte Corporation Kiadis Corporation |
AbbVie, Inc. Blueprint Medicines Celgene Corporation CTI BioPharma Corp. Novartis Pharmaceuticals Corporation |
Novartis Pharmaceuticals Corporation | None | 06/14/2022 |
| Rachel Salit MD | Incyte Corporation | CTI BioPharma Corp. | None | None | 05/23/2022 |
| Jamile Shammo MD | Apellis NS- Biopharma |
Alexion Pharmaceuticals, Inc. Bristol-Myers Squibb Company CTI BioPharma Corp. GlaxoSmithKline Novartis Pharmaceuticals Corporation |
Alexion Pharmaceuticals, Inc. Blueprint Medicines Incyte Corporation sanofi-aventis U.S. |
AbbVie, Inc. | 04/03/2023 |
| Moshe Talpaz MD | None | Bristol-Myers Squibb Company IMAGO Kyowa Kirin Novartis Pharmaceuticals Corporation Sierra Oncology Sumitomo |
None | None | 03/09/2023 |
| Pankit Vachhani MD | None | None | AbbVie, Inc. Blueprint Medicines Cogent Biosciences CTI BioPharma Corp. Daiichi- Sankyo Co. Genentech, Inc. GlaxoSmithKline Incyte Corporation Karyopharm Therapeutics LAVA therapeutics Servier |
None | 05/13/2023 |
| Martha Wadleigh MD | None | None | None | None | 01/23/2023 |
| Sarah Wall MD,MPH | AbbVie, Inc. CTI BioPharma Corp. Telios Pharma |
Bristol-Myers Squibb Company | None | None | 05/17/2023 |